LTR Pharma and Aptar Pharma have entered into a co-development agreement for Spontan The primary goal is commercialisation of ...

Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using market expertise, proprietary design, engineering and science ...

The conference will open with a Welcome Cocktail Reception on the evening of Tuesday, May 6, and Aptar Pharma will sponsor a Gala Dinner at a scenic location in Estoril on Thursday, May 8.

Digitalisation of health is one of Chiesi's core R&D objectives, and the alliance with Aptar isn't its first in the respiratory category, its largest therapeutic area accounting for €1.7 billion ...

Aptar said that adding Voluntis to its stable would allow help it develop a new generation of DTX for pharmaceutical and biotech customers, as well as other healthcare stakeholders including ...

Aptar Pharma, leader in respiratory drug delivery solutions, and RDD Online® are pleased to announce their co-organization of RDD® Europe 2025, which will be held in-person from Tuesday ...

CRYSTAL LAKE, Ill., February 27, 2025--(BUSINESS WIRE)--Aptar Pharma, leader in respiratory drug delivery solutions, and RDD Online ® are pleased to announce their co-organization of RDD ® Europe 2025 ...